Jul 18,2019

The Moovcare app, against lung cancer, soon to be reimbursed

Remote monitoring software in lung cancer, Moovcare, received a favorable opinion from the Haute Autorité de Santé for its reimbursement, which should be granted before the end of the year. HAS issued an advisory on April 9, favorable for support by the health insurance of Moovcare, developed by the Sivan company, with a service improvement note expected level III (moderate). At stretching the planned national launch at the end of 2019, the application has already been in disposal of about fifty patients in a dozen centers French, including the Institut Curie.

PRODUCT

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 31,2019

Voluntis announces market authorization for Oleena™, first digital therapeutic in oncology

Voluntis (Euronext Paris, Ticker: VTX – ISIN: FR0004183960), a leader in digital therapeutics, today announced it has successfully completed a U.S. Food and Drug Administration (FDA) regulatory review of its Oleena™ software for oncology-related symptoms management and remote patient monitoring. Oleena™ is determined as Class II medical device falling under enforcement discretion per FDA Guidance.

REGULATORY FDA

#dtx

#rpm

#coaching

View Analyst & Ambassador Comments
Go to original news
Aug 06,2018

Kaiku helps clinical staff provide better care for patients at Hirslanden

Hirslanden Private Hospital Group offers versatile healthcare services in its 17 hospitals in Switzerland. They have adopted Kaiku Health digital patient monitoring platform to improve treatment quality and patient safety. Hirslanden chose to use Kaiku Health for monitoring patient reported outcomes as they found the platform to best suit their needs.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Aug 28,2018

University Hospital of Zurich chooses Kaiku Health to improve the quality of care delivered to urological cancer patients

University Hospital of Zurich (USZ), one of the largest and most eminent teaching hospitals in Europe with approximately 1 500 physicians and scientists, selected Kaiku Health to automate patient-reported outcomes data collection from prostate and testicular cancer patients.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 17,2017

How Patient-Reported Outcome Measures help improve healthcare – 5 concrete examples from Kaiku Health users

Electronic patient-reported outcome measures (or ePROMs) are increasingly being used for gathering patient feedback to support clinical decision making and to produce valuable data on the overall impact of an intervention or treatment. Since 2012, we have been working with some of the leading European hospitals and clinics who have integrated Kaiku Health’s ePROMs into their workflows. The company shares 5 of the most impressive, concrete examples of how our customers have benefitted from using ePROMs.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 20,2016

Turku University Hospital implements Kaiku Health for their late-effect follow-up of childhood cancer

Finnish digital health company Netmedi has begun cooperation with Turku University Hospital (Tyks) Cancer Center’s late-effect follow-up clinic. Kaiku Health web application will be used to systematically collect data about current state of health and quality of life, as well as any possible late adverse events in patients that have undergone cancer treatment during childhood or adolescence. The collected data will also be used to analyze future medical research needs.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Jun 20,2016

Netmedi starts cooperation with the German HELIOS Clinics

Netmedi has started a cooperation with the helios.hub in Berlin as a first step to apply Kaiku Health platform for the digital follow-up of cancer patients during their therapy and recovery at the cancer clinics of the HELIOS Kliniken in Germany. helios.hub is the eHealth accelerator of the HELIOS Kliniken, the largest privately owned clinic chain in Germany. helios.hub supports start-ups to develop, test and bring digital applications into the clinical practice.

COLLABORATION PARTNERSHIP

#r&d

#rpm

View Analyst & Ambassador Comments
Go to original news
May 25,2016

Netmedi launches a digital solution for immuno-oncology follow-up at ASCO

Finnish health technology company Netmedi (now named Kaiku Health) has developed an innovative digital platform, Kaiku® Health IO, for the follow-up of patients treated with immune checkpoint inhibitors. The solution is about to enter multi-center clinical validation phase and has already attracted significant interest among a number of leading oncology clinics. Kaiku® Health IO provides a solution for enhanced management of immune-related adverse events, supporting patients and the care team throughout treatment and follow-up. Netmedi will launch Kaiku® Health IO Early Access Program at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 4th 2016.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
May 16,2016

ICHOM standard sets for cancer treatment outcomes integrated in Kaiku Health

Netmedi (now named Kaiku Health), the provider of Kaiku® Health digital service, makes ICHOM’s globally standardized sets of outcomes, Standard Sets, available in Kaiku® Health for all partner clinics. Kaiku® Health follows patients’ progress throughout cancer treatment and recovery by tracking adverse effects and critical values. Integration of ICHOM Standard Sets to Kaiku® Health allows comparison of treatment outcomes between health care centers internationally. Netmedi is the first ICHOM certified supplier in Finland.

PRODUCT

#rpm

#platform

View Analyst & Ambassador Comments
Go to original news
Jul 11,2019

Rimidi Expands its Cloud-Based Platform to Include Cardiovascular Disease

Rimidi, a cloud-based software platform that enables personalized management of chronic cardiometabolic conditions across populations, today announced it has added a new disease ‘view’ to its platform. Joining its type 2 diabetes, heart failure and nonalcoholic fatty liver views, the software will now support cardiovascular disease (CVD).

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM